06150KY
Bypass Superior Mesenteric Vein to Lower Vein with Nonautologous Tissue Substitute, Open Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 6 Lower Veins |
| Operation | 1 Bypass |
| Body Part | 5 Superior Mesenteric Vein |
| Approach | 0 Open |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Y Lower Vein |
Operation Definition
Altering the route of passage of the contents of a tubular body part
Procedure Overview
Bypass procedures on the lower veins create a new pathway for blood to flow around a blocked or damaged section of a vein in the leg, pelvis, or abdomen. Surgeons typically use a segment of the patient's own vein, a synthetic graft, or a section of another vessel to route blood past the obstruction, restoring normal circulation and relieving symptoms like swelling, pain, or skin changes caused by poor venous return.
This is most often performed for severe venous insufficiency, chronic deep vein thrombosis that has scarred a vein shut, or May-Thurne syndrome where the iliac vein is compressed. A well-known example is the Palma procedure, which reroutes blood from a blocked iliac vein across the pelvis into the healthy vein on the opposite side using a segment of the patient's own saphenous vein.
Anatomy & Axis Detail
Superior Mesenteric Vein
The superior mesenteric vein drains the small intestine and proximal colon and unites with the splenic vein behind the pancreatic neck to form the portal vein, making it a critical junction in mesenteric venous drainage. It can be thrombosed by hypercoagulable states or compressed by pancreatic or peripancreatic tumors, producing bowel congestion, ischemia, or contributing to portal hypertension. Bypass of the superior mesenteric vein reroutes flow around the obstruction, and this vessel is also frequently reconstructed during complex pancreatic resections such as the Whipple procedure when tumor is adherent to or invading the vein. The operative documentation should identify whether an interposition graft, patch, or direct anastomosis to another venous structure was used, since this affects device coding.
Approach: Open
Open approach means the surgeon cuts through skin, mucous membrane, or other tissue layers to physically expose the target site to view before performing the procedure. It gives direct visualization and hands-on access, distinguishing it from Percutaneous approaches where instruments pass through a small puncture without exposing the site. Open is typical for procedures needing wide access, such as most laparotomies.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Qualifier: Lower Vein
This qualifier marks a vein of the lower extremity, pelvis, or abdomen as the procedural target when no more specific named vessel is documented. It functions as the counterpart to Upper Vein, and the choice between the two depends solely on which general body region the treated vein belongs to.
Coding & Documentation
Coders need operative documentation naming both the vein being bypassed and where the new pathway terminates, since ICD-10-PCS bypass codes require identifying the qualifier vessel or body part that receives the rerouted flow. The type of conduit used, whether autologous vein, synthetic graft, or another patient tissue, is also captured in the device or qualifier character and must be pulled directly from the operative report.
A common mistake is defaulting to a same-vessel body part when the graft actually connects to a different named vein, which changes the qualifier value and can misrepresent the extent of the procedure. Coders also sometimes overlook that harvesting the graft vessel itself may warrant a separate Excision code if it's a distinct procedure rather than an inherent part of bypass graft preparation.